Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,692 | 142 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $672.63 | 35 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $512.99 | 37 | $0 (2024) |
| Janssen Biotech, Inc. | $420.19 | 22 | $0 (2024) |
| Vioptix Inc | $173.29 | 2 | $0 (2022) |
| Celgene Corporation | $129.03 | 8 | $0 (2023) |
| Janssen Scientific Affairs, LLC | $111.75 | 1 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $108.40 | 6 | $0 (2023) |
| Lilly USA, LLC | $95.08 | 5 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $71.02 | 3 | $0 (2024) |
| Merck Sharp & Dohme LLC | $60.82 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $651.20 | 28 | Janssen Biotech, Inc. ($149.09) |
| 2023 | $508.29 | 27 | Janssen Biotech, Inc. ($142.79) |
| 2022 | $649.58 | 29 | ABBVIE INC. ($231.82) |
| 2021 | $308.87 | 14 | Takeda Pharmaceuticals U.S.A., Inc. ($117.90) |
| 2020 | $122.96 | 8 | Janssen Biotech, Inc. ($42.27) |
| 2019 | $123.77 | 11 | Takeda Pharmaceuticals U.S.A., Inc. ($70.50) |
| 2018 | $59.04 | 6 | Takeda Pharmaceuticals U.S.A., Inc. ($59.04) |
| 2017 | $268.06 | 19 | AbbVie, Inc. ($152.39) |
All Payment Transactions
142 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/21/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Immunology | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Immunology | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $3.67 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Immunology | ||||||
| 09/11/2024 | Janssen Scientific Affairs, LLC | STELARA (Biological) | Food and Beverage | In-kind items and services | $111.75 | General |
| Category: Immunology | ||||||
| 08/22/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Immunology | ||||||
| 08/20/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Immunology | ||||||
| 08/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Gastroenterology | ||||||
| 07/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/08/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: Immunology | ||||||
| 07/02/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: IMMUNOLOGY | ||||||
| 06/11/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: Immunology | ||||||
| 04/25/2024 | Medtronic, Inc. | EEA (Device) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Surgical Stapling | ||||||
| 04/11/2024 | Smith+Nephew, Inc. | PICO 7 (Device) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: Negative Pressure Wound Therapy | ||||||
| 03/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: IMMUNOLOGY | ||||||
| 03/05/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 628 | 731 | $222,175 | $81,551 |
| 2022 | 16 | 628 | 736 | $218,673 | $80,837 |
| 2021 | 17 | 674 | 807 | $213,280 | $83,364 |
| 2020 | 13 | 500 | 621 | $138,685 | $56,571 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 57 | 57 | $37,050 | $10,766 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 135 | 160 | $23,200 | $9,822 | 42.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 51 | 60 | $16,855 | $8,189 | 48.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 37 | 37 | $27,750 | $7,960 | 28.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 40 | 40 | $26,000 | $7,577 | 29.1% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2023 | 26 | 32 | $14,400 | $7,186 | 49.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 71 | $12,780 | $6,416 | 50.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 74 | 74 | $14,800 | $5,841 | 39.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 39 | 39 | $25,350 | $5,802 | 22.9% |
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2023 | 40 | 41 | $8,810 | $3,631 | 41.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 32 | 84 | $6,300 | $3,423 | 54.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $5,760 | $2,831 | 49.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $3,120 | $2,106 | 67.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 133 | 157 | $22,765 | $10,448 | 45.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 52 | 53 | $34,450 | $10,241 | 29.7% |
| 46221 | Removal of external hemorrhoids by rubber banding | Office | 2022 | 27 | 35 | $14,000 | $8,328 | 59.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 35 | 36 | $27,000 | $7,684 | 28.5% |
| 45384 | Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery | Facility | 2022 | 44 | 44 | $28,600 | $7,212 | 25.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 59 | 74 | $13,320 | $7,008 | 52.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 73 | 73 | $14,600 | $5,591 | 38.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $8,880 | $4,953 | 55.8% |
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2022 | 40 | 44 | $6,600 | $3,991 | 60.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 20 | 20 | $13,000 | $3,733 | 28.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 23 | 23 | $14,950 | $3,284 | 22.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 33 | 87 | $6,525 | $2,815 | 43.1% |
About Dr. Jon Hain, MD
Dr. Jon Hain, MD is a Colon & Rectal Surgery healthcare provider based in Rochester Hills, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1497720288.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jon Hain, MD has received a total of $2,692 in payments from pharmaceutical and medical device companies, with $651.20 received in 2024. These payments were reported across 142 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,692).
As a Medicare-enrolled provider, Hain has provided services to 2,430 Medicare beneficiaries, totaling 2,895 services with total Medicare billing of $302,321. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty Colon & Rectal Surgery
- Location Rochester Hills, MI
- Active Since 02/23/2006
- Last Updated 07/08/2007
- Taxonomy Code 208C00000X
- Entity Type Individual
- NPI Number 1497720288
Products in Payments
- STELARA (Biological) $472.70
- RINVOQ (Biological) $356.68
- ENTYVIO (Biological) $313.18
- Humira (Biological) $168.96
- Entyvio (Biological) $150.74
- ZEPOSIA (Drug) $129.03
- T. Ox Tissue Oximeter (Device) $113.94
- GATTEX (Drug) $84.36
- OMVOH (Drug) $76.67
- XIFAXAN (Drug) $71.02
- CIMZIA (Drug) $69.59
- DIFICID (Drug) $60.82
- TREMFYA (Drug) $59.24
- Cimzia (Drug) $57.83
- HUMIRA (Biological) $55.11
- XELJANZ (Drug) $50.30
- SKYRIZI (Biological) $49.65
- LINZESS (Drug) $42.23
- REBYOTA (Biological) $38.81
- EOHILIA (Drug) $35.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Colon & Rectal Surgery Doctors in Rochester Hills
Dr. Kenneth Bark, M.d, M.D
Colon & Rectal Surgery — Payments: $82,837
Jasneet Bhullar, M.d, M.D
Colon & Rectal Surgery — Payments: $37,880
Dr. Raymond Landes, Md, MD
Colon & Rectal Surgery — Payments: $2,254
Dr. Yongjin Lee, M.d, M.D
Colon & Rectal Surgery — Payments: $825.88
Dr. Michael Henein, M.d, M.D
Colon & Rectal Surgery — Payments: $270.82
Dr. James Lynch, Md, MD
Colon & Rectal Surgery — Payments: $22.06